中药精油干预阿尔茨海默病的最新研究进展

刘菁, 顾志荣, 张诗烨, 赵丽婷, 葛斌

中国新药杂志 ›› 2026, Vol. 35 ›› Issue (15) : 1620 -1626.

PDF (1250KB)
中国新药杂志 ›› 2026, Vol. 35 ›› Issue (15) : 1620 -1626. DOI: 10.20251/j.cnki.1003-3734.2026.15.007
综述

中药精油干预阿尔茨海默病的最新研究进展

    刘菁1, 顾志荣2*, 张诗烨1, 赵丽婷1, 葛斌2*
作者信息 +

Recent advances of intervention of Chinese herbal essential oils in Alzheimer's disease

    LIU Jing1, GU Zhi-rong2*, ZHANG Shi-ye1, ZHAO Li-ting1, GE Bin2*
Author information +
文章历史 +
PDF (1279K)

摘要

阿尔茨海默病(Alzheimer's disease,AD)是一种多因素协同作用的神经退行性疾病,当前的治疗药物仅能缓解症状,不能治愈或预防。大量研究证实,中药精油可采用吸入、局部涂抹和口服等给药途径,通过抗β-淀粉样蛋白(amyloid beta protein,Aβ)沉积、抗Tau蛋白异常磷酸化、抗氧化应激、抗炎、抗胆碱酯酶、调节糖代谢等多个途径,改善AD病理特征,抑制神经毒性与细胞凋亡,减少神经元损伤,改善认知功能障碍。本文系统归纳中药精油干预AD的作用、分子机制及给药途径,总结目前研究存在的问题及未来发展方向,为相关基础研究及新药研发提供参考。

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder caused by the synergistic interplay of multiple factors. Current treatments are only able to alleviate symptoms and cannot cure or prevent it. Numerous studies have demonstrated that Chinese herbal essential oils can be administered through inhalation, topical application, and oral administration. Via multiple pathways including anti-amyloid-beta (Aβ) deposition, anti-abnormal Tau protein hyperphosphorylation, anti-oxidant stress, anti-inflammatory, anticholinesterase activity, and regulation of glucose metabolism, these oils improve the pathological features of AD, inhibit neurotoxicity and cell apoptosis, reduce neuronal damage, and ameliorate cognitive dysfunction. This paper systematically reviews the effects, molecular mechanisms, and administration routes of Chinese herbal essential oils intervening in AD, summarizes current research limitations and future development directions, and provides a reference for related basic research and new drug development.

关键词

中药精油 / 阿尔茨海默病 / 分子机制 / 神经保护 / 多靶点干预

Key words

Chinese herbal essential oils / Alzheimer's disease / molecular mechanisms / neuroprotection / multi-target intervention

引用本文

引用格式 ▾
刘菁, 顾志荣, 张诗烨, 赵丽婷, 葛斌. 中药精油干预阿尔茨海默病的最新研究进展[J]. 中国新药杂志, 2026, 35(15): 1620-1626 DOI:10.20251/j.cnki.1003-3734.2026.15.007

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1] WANG YQ, JIA RX, LIANG JH, et al. Dementia in China (2015-2050) estimated using the 1% population sampling survey in 2015[J]. Geriatr Gerontol Int, 2019, 19(11): 1096-1100.
[2] SRIVASTAVA S, AHMAD R, KHARE SK. Alzheimer's disease and its treatment by different approaches: a review[J]. Eur J Med Chem, 2021, 216: 113320.
[3] SHARMA K. Cholinesterase inhibitors as Alzheimer's therapeutics (review)[J]. Mol Med Rep, 2019, 20(2): 1479-1487.
[4] DYER O. Injectable Alzheimer's drug lecanemab approved in US for use at home[J]. BMJ, 2025, 390: r1888.
[5] FEDELE E. Anti-amyloid therapies for Alzheimer's disease and the amyloid cascade hypothesis[J]. Int J Mol Sci, 2023, 24(19): 14499.
[6] ALAFUZOFF I, ARZBERGER T, AL-SARRAJ S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe consortium[J]. Brain Pathol, 2008, 18(4): 484-496.
[7] ANGELONI C, MALAGUTI M, HRELIA S. Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?[J]. Neural Regen Res, 2015, 10(11): 1750-1751.
[8] WU YG, SONG LJ, YIN LJ, et al. The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease[J]. Neural Regen Res, 2023, 18(5): 947-954.
[9] BENEK O, AITKEN L, HROCH L, et al. A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer's disease[J]. Curr Med Chem, 2015, 22(9): 1056-1085.
[10] MAHLEY RW. Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease[J]. Curr Opin Neurobiol, 2023, 79: 102684.
[11] CHORNENKYY Y, WANG WX, WEI A, et al. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline[J]. Brain Pathol, 2019, 29(1): 3-17.
[12] KHAN S, BARVE KH, KUMAR MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease[J]. Curr Neuropharmacol, 2020, 18(11): 1106-1125.
[13] 刘立权, 江萌, 张伊黎, 等. 石菖蒲挥发油成分改善阿尔茨海默病症状的作用及机制研究[J]. 浙江医学, 2024, 46(11): 1151-1156.
[14] 胡慧艳, 文志强, 任婧婻, 等. 嗅闻佛手柑精油对阿尔兹海默症小鼠的神经行为的影响[J]. 华中农业大学学报, 2022(4): 151-157.
[15] 崔勇华. 佛手精油对阿尔茨海默症模型动物和细胞的神经保护作用及其分子机制研究[D]. 无锡: 江南大学博士论文, 2023: 1-85.
[16] 陈紫微, 张前, 何芳, 等. 栀子花精油芳香疗法对阿尔兹海默症双转基因模型小鼠运动及焦虑的影响[J]. 北京中医药大学学报, 2020, 43(7): 569-574.
[17] 齐越, 刘冉, 贾冬, 等. 温郁金挥发油对Aβ25-35致阿尔兹海默病小鼠模型行为学的影响[J]. 实验动物科学, 2017, 34(5): 23-27.
[18] BAHADORI BM, MAGGI F, ZENGIN G, et al. Essential oils of hedgenettles (Stachys inflata, S. lavandulifolia, and S. byzantina) have antioxidant, anti-Alzheimer, antidiabetic, and anti-obesity potential: A comparative study[J]. Ind Crops Prod, 2020, 145: 112089.
[19] MURAKAMI Y, OHSAWA I, KASAHARA T, et al. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde[J]. Neurobiol Aging, 2009, 30(2): 325-329.
[20] HARA Y, MCKEEHAN N, FILLIT HM. Translating the biology of aging into novel therapeutics for Alzheimer disease[J]. Neurology, 2019, 92(2): 84-93.
[21] CHONG CM, SU HX, LU JJ, et al. The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer's disease[J]. Chin Med, 2019, 14: 19.
[22] 齐越, 秦文艳, 康凯, 等. 温郁金挥发油通过PI3K/Akt信号途径对阿尔茨海默模型小鼠tau蛋白磷酸化表达的影响[J]. 中国中医药信息杂志, 2017, 24(1): 45-48.
[23] JEON S, HUR J, JEONG HJ, et al. SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice[J]. Am J Chin Med, 2011, 39(5): 917-932.
[24] ZUO X, GU YN, WANG C, et al. A systematic review of the anti-inflammatory and immunomodulatory properties of 16 essential oils of herbs[J]. Evid Based Complement Alternat Med, 2020, 2020: 8878927.
[25] 宋琳, 敖丽梅, 朴钟源, 等. 中药对阿尔茨海默病抗氧化作用的实验研究进展[J]. 上海中医药杂志, 2016, 50(4): 97-101.
[26] LV XF, FENG YY, MA R, et al. Effects of peppermint essential oil on learning and memory ability in APP/PS1 transgenic mice[J]. Molecules, 2022, 27(7): 2051.
[27] AL-TAWARAH NM, AL-DMOUR RH, ABU HAJLEH MN, et al. Rosmarinus officinalis and Mentha piperita oils supplementation enhances memory in a rat model of scopolamine-induced Alzheimer's disease-like condition[J]. Nutrients, 2023, 15(6): 1547.
[28] XU ZW, ZHOU XJ, HONG X, et al. Essential oil of Acorus tatarinowii Schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 × Tg-AD transgenic mice[J]. Phytomedicine, 2023, 112: 154695.
[29] 邓敏贞, 黄丽平, 马阮昕, 等. 石菖蒲挥发油联合人参总皂苷通过调节PI3K/Akt/mTOR通路对痴呆模型APP/PS1双转基因小鼠的Aβ40和GFAP的影响[J]. 中药药理与临床, 2018, 34(4): 92-95.
[30] SAXENA M, DUBEY R. Target enzyme in Alzheimer's disease: acetylcholinesterase inhibitors[J]. Curr Top Med Chem, 2019, 19(4): 264-275.
[31] BOIANGIU RS, BAGCI E, DUMITRU G, et al. Angelica purpurascens (avé-lall.) gilli. essential oil improved brain function via cholinergic modulation and antioxidant effects in the scopolamine-induced zebrafish (Danio rerio) model[J]. Plants (Basel), 2022, 11(8): 1096.
[32] LIU BN, KOU JY, LI FY, et al. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase[J]. Aging (Albany NY), 2020, 12(9): 8622-8639.
[33] MEDEIROS SRNA, BEZERRA IC, PEDROZA LAL, et al. Evaluation of Bauhinia ungulata Essential Oil as a New Acetylcholinesterase Inhibitor from an in silico and in vitro Perspective in the Northern Amazon of Brazil[J]. J Oleo Sci, 2024, 73(8): 1091-1104.
[34] TERAL? K, OZBEYLI D, YIĞIT-HANŇLU D, et al. A comprehensive assessment of the cholinergic-supporting and cognitive-enhancing effects of Rosa damascena Mill. (Damask rose) essential oil on scopolamine-induced amnestic rats[J]. Brain Behav, 2024, 14(5): e3507.
[35] ZHOU DD, LUO M, HUANG SY, et al. Effects and mechanisms of resveratrol on aging and age-related diseases[J]. Oxid Med Cell Longev, 2021, 2021: 9932218.
[36] ZHAO X, HUANG XS, YANG C, et al. Artemisinin attenuates amyloid-induced brain inflammation and memory impairments by modulating TLR4/NF-κB signaling[J]. Int J Mol Sci, 2022, 23(11): 6354.
[37] ASHOKKUMAR K, SIMAL-GANDARA J, MURUGAN M, et al. Nutmeg (Myristica fragrans Houtt.) essential oil: a review on its composition, biological, and pharmacological activities[J]. Phytother Res, 2022, 36(7): 2839-2851.
[38] XU QQ, SU ZR, YANG W, et al. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway[J]. J Neuroinflammation, 2023, 20(1): 19.
[39] MOHAMED ME, YOUNIS NS, EL-BELTAGI HS, et al. The synergistic hepatoprotective activity of rosemary essential oil and curcumin: the role of the MEK/ERK pathway[J]. Molecules, 2022, 27(24): 8910.
[40] BEJESHK MA, SAMAREH FEKRI M, NAJAFIPOUR H, et al. Anti-inflammatory and anti-remodeling effects of myrtenol in the lungs of asthmatic rats: Histopathological and biochemical findings[J]. Allergol Immunopathol (Madr), 2019, 47(2): 185-193.
[41] ALAHMADY NF, ALKHULAIFI FM, ABDULLAH MM, et al. Biochemical characterization of chamomile essential oil: Antioxidant, antibacterial, anticancer and neuroprotective activity and potential treatment for Alzheimer's disease[J]. Saudi J Biol Sci, 2024, 31(2): 103912.
[42] LIU FG, YANG YF, DONG HR, et al. Essential oil from Cinnamomum cassia Presl bark regulates macrophage polarization and ameliorates lipopolysaccharide-induced acute lung injury through TLR4/MyD88/NF-κB pathway[J]. Phytomedicine, 2024, 129: 155651.
[43] 李文静, 肖帅, 郑琴, 等. 基于GC-MS技术和网络药理学探讨益智仁挥发油治疗阿尔茨海默病的作用机制[J]. 中国中药杂志, 2021, 46(12): 3052-3057.
[44] CHORNENKYY Y, WANG WX, WEI A, et al. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline[J]. Brain Pathol, 2019, 29(1): 3-17.
[45] HUANG JH, XU ZW, YU CS, et al. The volatile oil of Acorus tatarinowii Schott ameliorates Alzheimer's disease through improving insulin resistance via activating the PI3K/AKT pathway[J]. Phytomedicine, 2024, 135: 156168.
[46] CHA H, KIM S, SEO MS, et al. Effects of olfactory stimulation on cognitive function and behavior problems in older adults with dementia: a systematic literature review[J]. Geriatr Nurs, 2021, 42(5): 1210-1217.
[47] 苗明三, 李孟艳, 田硕. 中药外用疗效新机制[J]. 中国药理学与毒理学杂志, 2019, 33(9): 653-654.
[48] VORA LK, GHOLAP AD, HATVATE NT, et al. Essential oils for clinical aromatherapy: a comprehensive review[J]. J Ethnopharmacol, 2024, 330: 118180.
[49] MA Y, LI YM, YIN R, et al. Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms[J]. CNS Neurosci Ther, 2023, 29(8): 2045-2059.
[50] SHI A, LONG Y, MA Y, et al. Natural essential oils derived from herbal medicines: a promising therapy strategy for treating cognitive impairment[J]. Front Aging Neurosci, 2023, 15: 1104269.
[51] AVOLA R, FURNARI AG, GRAZIANO ACE, et al. Management of the brain: essential oils as promising neuroinflammation modulator in neurodegenerative diseases[J]. Antioxidants (Basel), 2024, 13(2): 178.

基金资助

甘肃省药品监督管理局药品监管科学研究项目—青年科技创新(2023GSMPA046);甘肃省自然科学基金资助项目(24JRRA1061);吴阶平医学基金会药学专项基金资助项目(320.6750.2025-6-32);中国健康促进基金会“公立医院高质量发展科研公益项目”

AI Summary AI Mindmap
PDF (1250KB)

6

访问

0

被引

详细

导航
相关文章

AI思维导图

/